Citations

Clear

5 citation(s) found for "Grassi, Marcello".

Nuclear Magnetic Resonance-Based Glomerular Filtration Rate Estimation Is More Closely Associated with Serum Vancomycin Target Trough Achievement vs. Serum Creatinine-Based Equations
Barreto, Jason N. , Santamaría, Amauri Schwäble , Grassi, M , Robertson, Andrew, Meeusen, Jeff W., Schiffer, Eric, Frazee, Erin N. , Schwäble Santamaria, Amauri , Grassi, Marcello, Lieske, John C. , Meeusen, Jeffrey W.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024cxwpvjcv Get It

Correction: Stämmler et al. Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C. Diagnostics 2021, 11, 2291
Stämmler, Frank , Grassi, M , Meeusen, Jeffrey W. , Lieske, John C. , Dasari, Surendra , Dubourg, Laurence , Ehrich, J. H. H. , Schiffer, Eric, Grassi, Marcello , Lieske, John C , Lemoine, Sandrine

Mayo Clinic

Diagnostics | September 3, 2024 | Volume: 14 | Issue: 17 | Pages: 1949

10.3390/diagnostics14171949 | PMID 39272782 Get It

In the original publication [...]
Performance of a Novel Race-Independent GFR Estimating Equation in Kidney Transplant Recipients Based on NMR-Measured Metabolites
Meeusen, Jeff W., Dasari, Surendra , Grassi, M , Stämmler, Frank , Schiffer, Eric, Meeusen, Jeffrey W. , Lieske, John C. , Grassi, Marcello

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 256-256

10.1681/asn.20223311s1256b Get It

Performance of Nuclear Magnetic Resonance-Based Estimated Glomerular Filtration Rate in a Real-World Setting
Santamaría, Amauri Schwäble , Grassi, M , Meeusen, Jeffrey W. , Lieske, John C. , Scott, Renee, Robertson, Andrew, Schiffer, Eric, Schwäble Santamaria, Amauri , Grassi, Marcello , Lieske, John C

Mayo Clinic

Bioengineering | June 14, 2023 | Volume: 10 | Issue: 6 | Pages: 717

10.3390/bioengineering10060717 | PMID 37370648 Get It

An accurate estimate of glomerular filtration rate (eGFR) is essential for proper clinical management, especially in patients with kidney dysfunction. This prospective observational study evaluated the real-world performance of the nuclear magnetic resonance (NMR)-based GFRNMR equation, which combines creatinine, cystatin C, valine, and myo-inositol with age and sex. We compared GFRNMR performance to that of the 2021 CKD-EPI creatinine and creatinine-cystatin C equations (CKD-EPI2021Cr and CKD-EPI2021CrCys), using 115 fresh routine samples of patients scheduled for urinary iothalamate clearance measurement (mGFR). Median bias to mGFR of the three eGFR equations was comparably low, ranging from 0.4 to 2.0 mL/min/1.73 m2. GFRNMR outperformed the 2021 CKD-EPI equations in terms of precision (interquartile range to mGFR of 10.5 vs. 17.9 mL/min/1.73 m2 for GFRNMR vs. CKD-EPI2021CrCys; p = 0.01) and accuracy (P15, P20, and P30 of 66.1% vs. 48.7% [p = 0.007], 80.0% vs. 60.0% [p < 0.001] and 95.7% vs. 86.1% [p = 0.006], respectively, for GFRNMR vs. CKD-EPI2021CrCys). Clinical parameters such as etiology, comorbidities, or medications did not significantly alter the performance of the three eGFR equations. Altogether, this study confirmed the utility of GFRNMR for accurate GFR estimation, and its potential value in routine clinical practice for improved medical care.
Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C
Stämmler, Frank , Grassi, M , Meeusen, Jeffrey W. , Lieske, John C. , Dasari, Surendra , Dubourg, Laurence , Ehrich, J. H. H. , Schiffer, Eric, Lieske, John C , Grassi, Marcello , Lemoine, Sandrine

Mayo Clinic

Diagnostics | December 7, 2021 | Volume: 11 | Issue: 12 | Pages: 2291

10.3390/diagnostics11122291 | PMID 34943527 Get It

Assessment of renal function relies on the estimation of the glomerular filtration rate (eGFR). Existing eGFR equations, usually based on serum levels of creatinine and/or cystatin C, are not uniformly accurate across patient populations. In the present study, we expanded a recent proof-of-concept approach to optimize an eGFR equation targeting the adult population with and without chronic kidney disease (CKD), based on a nuclear magnetic resonance spectroscopy (NMR) derived ‘metabolite constellation’ (GFRNMR). A total of 1855 serum samples were partitioned into development, internal validation and external validation datasets. The new GFRNMR equation used serum myo-inositol, valine, creatinine and cystatin C plus age and sex. GFRNMR had a lower bias to tracer measured GFR (mGFR) than existing eGFR equations, with a median bias (95% confidence interval [CI]) of 0.0 (−1.0; 1.0) mL/min/1.73 m2 for GFRNMR vs. −6.0 (−7.0; −5.0) mL/min/1.73 m2 for the Chronic Kidney Disease Epidemiology Collaboration equation that combines creatinine and cystatin C (CKD-EPI2012) (p < 0.0001). Accuracy (95% CI) within 15% of mGFR (1-P15) was 38.8% (34.3; 42.5) for GFRNMR vs. 47.3% (43.2; 51.5) for CKD-EPI2012 (p < 0.010). Thus, GFRNMR holds promise as an alternative way to assess eGFR with superior accuracy in adult patients with and without CKD.